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Abstract – Haemophilus parasuis is a colonizer of the upper respiratory tract of healthy pigs, but
virulent strains can cause a systemic infection characterized by ﬁbrinous polyserositis, commonly
known as Gla¨sser’s disease. The variability in virulence that is observed among H. parasuis strains is
not completely understood, since the virulence mechanisms of H. parasuis are largely unknown. In
the course of infection, H. parasuis has to survive the host pulmonary defences, which include
alveolar macrophages, to produce disease. Using strains from different clinical backgrounds, we were
able to detect clear differences in susceptibility to phagocytosis. Strains isolated from the nose of
healthy animals were efﬁciently phagocytosed by porcine alveolar macrophages (PAM), while strains
isolated from systemic lesions were resistant to this interaction. Phagocytosis of susceptible strains
proceeded through mechanisms independent of a speciﬁc receptor, which involved actin ﬁlaments
and microtubules. In all the systemic strains tested in this study, we observed a distinct capsule after
interaction with PAM, indicating a role of this surface structure in phagocytosis resistance. However,
additional mechanisms of resistance to phagocytosis should be explored, since we detected different
effects of microtubule inhibition among systemic strains.
phagocytosis resistance / Haemophilus parasuis / alveolar macrophages / strain variability
1. INTRODUCTION
Haemophilus parasuis is a member of
the c-proteobacteria family Pasteurellaceae.
Although it was ﬁrst described as the etiological
agent of Gla¨sser’s disease, it is also known as a
common inhabitant of the upper respiratory
tract of healthy pigs. Besides Gla¨sser’s disease,
which is characterized by ﬁbrinous polyserositis
and arthritis, it also produces pneumonia and
sudden death in swine [24]. H. parasuis strains
differ in their virulence from highly virulent to
non virulent [23], and it has been shown that
they can be genetically divided in two major
clades, one of them associated with production
of systemic disease [22].
However, little is known about the mecha-
nisms that allow virulent H. parasuis strains
to cause disease. Recently, several groups have
sought to identify the virulence factors of this
bacterium using genomic methods [8, 12, 15,
16], but a direct demonstration of the impor-
tance of the selected genes to virulence has
not been shown.
Older reports showed a correlation between
the degree of virulence and the serotype of
the strain [19, 25], suggesting a role of
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lipooligosaccharide (LOS) and/or other poly-
saccharides in the virulence of this species.
Recent studies on the function of LOS indicate
a partial role of this molecule in adhesion to and
release of IL-8 and IL-6 by endothelial cells [2,
29]. It is also noteworthy that capsule produc-
tion was shown to be enhanced after in vivo
passage, but it was produced by all strains
tested, including non-virulent reference strains
[24]. Conversely, a previous report indicated
that strains associated with pathological condi-
tions were uncapsulated [17]. Thus, association
of capsule with H. parasuis virulence remains a
controversial issue due to the difﬁculty in
detecting capsule production and the lack of
reproducibility of the ﬁndings.
In 1995, Vahle et al. [28] studied the dynam-
ics of infection with H. parasuis after intranasal
inoculation with a systemic isolate. In those
studies, H. parasuis was recovered from lung
tissue before any other systemic organ and prior
to systemic disease onset. Recently, our group
proposed that serum resistance was a virulence
mechanism linked to the ability of virulent
strains to produce systemic infection [4]. How-
ever, based on the dynamics of infection,
H. parasuis has to ﬁrst reach the lung and sur-
vive the host pulmonary defences before invad-
ing the blood stream. In the lung, bacteria have
to confront alveolar macrophages, whose main
function is to clear infection through phagocy-
tosis of invading microorganisms. Since resis-
tance to phagocytosis is a common trait of
virulent Pasteurellaceae [7, 10, 11, 20], the
aim of this study was to determine if resistance
to phagocytosis is also a virulence mechanism
of H. parasuis. Here, we report that H. parasuis
strains from different clinical origin present dif-
ferent susceptibility to phagocytosis by porcine
alveolar macrophages (PAM).
2. MATERIALS AND METHODS
2.1. Porcine alveolar macrophages isolation
All procedures involving animals followed EU
normative (Council Directive 86/609/EEC) and were
performed with institutional authorization. Prior to
the collection of bronchoalveolar ﬂuid, four healthy
pigs from different conventional herds were eutha-
nized by intravenous sodium pentobarbital overdose.
Bronchoalveolar lavage of the lungs was performed
with 100 mL aliquots of sterile PBS containing gen-
tamicin at 70 lg/mL (Sigma-Aldrich, Madrid,
Spain). To collect the PAM, lavage ﬂuids were centri-
fuged at 230 · g for 15 min, and cells were washed
twice with Dulbecco’s Modiﬁed Eagle’s Medium
(DMEM) containing gentamicin (50 lg/mL). Con-
centration of PAM was adjusted to 1 · 107 cells/
mL and aliquots were stored at 150 C in DMEM
with 10% of DMSO, 20% fetal bovine serum (FBS).
PAM isolation was conﬁrmed by detection of macro-
phage markers (SWC3, CD169 and SLAII) in the
cells by ﬂow cytometry.
2.2. Fluorescein labelling of H. parasuis strains
Eight H. parasuis ﬁeld strains and the reference
strains Nagasaki (virulent) and SW114 (non-virulent)
were used in this study (Tab. I). Strains were grown
on chocolate agar at 37 C and 5% CO2, and the sub-
sequent overnight, non-conﬂuent growth was har-
vested from the plates and resuspended in PBS at
an OD660nm between 0.6 and 1.3, depending on the
strain (spectrophotometer VIS 7200; Dinko Instru-
ments, Barcelona, Spain). Two milliliters of these
suspensions were centrifuged at 11 000 · g for
5 min and the bacterial pellet was resuspended in
1 mL of PBS containing ﬂuorescein isothiocyanate
(FITC, from Sigma-Aldrich) at 100 lg/mL. After
incubation for 45 min at 37 C and 225 r.p.m.,
labelled bacteria were washed two times with com-
plete DMEM and resuspended to a ﬁnal volume of
0.5 mL in the same medium. To determine the ﬁnal
bacterial concentration after labelling and washing,
ten fold dilutions were plated on chocolate agar.
The concentration of the ﬁnal inoculum was approx-
imately 109 CFU/mL. To conﬁrm ﬂuorescent label-
ling, 10 lL samples were examined under a
ﬂuorescence microscope.
2.3. Phagocytosis assays
The basic phagocytosis assay was performed as
described before [27], with some modiﬁcations.
PAM were seeded in 6-well plates (NUNC, Fisher
Bioblock Scientiﬁc, Madrid, Spain) at a concentra-
tion of 5 · 105 cells in 3 mL of DMEM supple-
mented with 10% FBS and 1% L-glutamine
(complete DMEM) per well. After attachment of
the cells to the plates, duplicate wells were inoculated
with FITC-labelled bacteria at a multiplicity of infec-
tion (MOI) of 100–200. After 1 h of incubation,
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plates were transferred to an ice bath to stop phago-
cytosis and supernatants were removed, centrifuged
at 11 000 · g for 5 min and the pellet used for cap-
sule staining (see below). PAM were then washed
twice with 3 mL of complete DMEM and once with
3 mL of PBS. After the washes, PAM were scraped
into 0.5 mL of 0.1% BSA in PBS and the cell sus-
pensions were analyzed by ﬂow cytometry in an
EPICS XL-MCLTM Flow Cytometer (Beckman
Coulter, Madrid, Spain). Assays were repeated using
PAM from different animals.
2.3.1. Bacterial survival after phagocytosis
Survival of four of the strains after phagocytosis
was examined. PAM were seeded in 24 well plates
at 5 · 105 cells/well and bacteria were added to an
MOI of 100–200. After 1 h of incubation to allow
uptake of bacteria, wells were washed three times
and complete DMEM with or without gentamicin
(100 lg/mL) and penicillin G (5 lg/mL) was added
to the wells. Incubation proceeded for 0, 2 or 5 addi-
tional hours. At those times, wells were washed again
and PAM were lysed with 500 lL of distilled water
and physical disruption by pipetting. Surviving bacte-
ria were counted by plating dilutions on chocolate
agar plates.
2.3.2. Opsonization and extracellular detection of
H. parasuis
A 1:1 mixture (v/v) of hyperimmune rabbit sera
against strains Nagasaki and SW114 [4] was used
to opsonize H. parasuis strains before phagocytosis
by PAM. As a control for speciﬁcity, a H. parasuis
non-speciﬁc rabbit antiserum, directed against chol-
era toxoid (TCC), was also used. Opsonization was
performed by incubation of the different FITC-
labelled bacterial suspensions with the same volume
of the inactivated rabbit serum at 37 C and
200 r.p.m. for 45 min. The opsonized strains were
washed to eliminate free antibody before use in the
phagocytosis assay. In addition, fresh non-immunized
rabbit serum was used to opsonize virulent strains to
test the effect of complement opsonization on
phagocytosis.
The same mixture of hyperimmune sera was used
to verify the internalization of the bacteria by PAM.
For extracellular detection of H. parasuis after incu-
bation with PAM, wells were washed to eliminate
unbound bacteria and were incubated with a dilution
of hyperimmune sera (6 lL sera in 500 lL of 0.1%
BSA in PBS). Plates were incubated for 60 min at
225 r.p.m. on ice. After three washes with 0.1%
BSA in PBS, cells were incubated with phycoery-
thrin (PE)-conjugated anti-rabbit IgG (Sigma). After
washing, ﬂuorescence associated to the PAM was
measured by ﬂow cytometry (FITC, total bacteria
and PE, extracellular bacteria).
2.3.3. Microscopy and image analysis
PAM were plated at a concentration of
2 · 105 cells/well in a chamber slide (NUNC Lab-
Tek) and were subsequently infected with one nasal
(SW114) and three systemic (264/99, ER6-P and
PC4-6P) FITC-labelled strains at a MOI = 50–100.
After 1 h of incubation, phagocytosis was stopped
by chilling the slides on ice. PAM were then washed
twice with complete DMEM, once with PBS,
ﬁxed with 4% paraformaldehyde for 10 min and
Table I. Signiﬁcant characteristics of the H. parasuis strains used in this study.
Strain Isolation site Disease status or lesions Serotype Serum susceptibilitya Reference
Nagasakib Systemic Fibrinous polyserositis 5 Resistant [14]
264/99 Systemic Fibrinous polyserositis 10 Resistant [21]
ER-6P Systemic Fibrinous polyserositis 15 Resistant [22]
PC4-6P Systemic Fibrinous polyserositis 12 Resistant [22]
SW114c Unknown Healthy 3 Sensitive [14]
F9 Nose Healthy 6 Sensitive [22]
SC14-1 Nose Healthy 15 Sensitive [21]
MU21-2 Nose Healthy 7 Sensitive [21]
167/03 Lung Unknown 15 Sensitive [21]
2757 Lung Pneumonia and pleuritis 1 Sensitive [21]
a From [4], except data for F9 which was produced for this study; b virulent reference strain; c non-virulent
reference strain.
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permeabilized with 0.5% Triton X-100 in PBS for
25 min, at RT. The cells were then stained with
tetramethylrhodamine B isothiocyanate-phalloidin
(50 lg/mL), counterstained with DAPI (1 lg/mL)
and mounted in Vectashield.
Preparations were viewed on a Nikon eclipse 90i
epiﬂuorescence microscope (· 100/NA 1.3 objec-
tive). To asses the association of bacteria with
PAM, we captured image stacks of cells using a Leica
TCS SP2 confocal microscope (· 63/NA 1.4 objec-
tive). Z stack images were acquired at intervals of
0.3 lm. Images were processed by using the LCS
from Leica and Image J software v3.91 software1.
2.3.4. Phagocytosis inhibitors
To explore the role of actin ﬁlaments and micro-
tubules in the phagocytosis process, PAM were incu-
bated with 1 lg/mL of cytochalasin D (cytD) or
10 lM colchicine (both from Sigma-Aldrich) 2 h
before and during the phagocytosis assay. Also, bac-
terial protein synthesis was inhibited by adding
100 lg/mL of chloramphenicol to the phagocytosis
assay. In both assays, detection of total and extracel-
lular bacteria was performed as described above.
2.4. Maneval capsule staining
Samples of FITC-labelled strains were examined
by Maneval staining for detection of capsule [5]
before and after the incubation with PAM. Prepara-
tions were observed with a Nikon eclipse 90i micro-
scope equipped with a Nikon DXM 1200F camera.
3. RESULTS
3.1. Virulent strains of H. parasuis avoid
phagocytosis
Phagocytosis assays with different concen-
trations of FITC-labelled Nagasaki and
SW114 (virulent and non-virulent reference
strains, respectively) indicated a clear difference
in the interaction of these two strains with
PAM. While the non-virulent strain SW114
associated with a high percentage of PAM,
the virulent strain Nagasaki did not associate
with PAM (Fig. 1A). Different incubation times
were also tested to optimize phagocytosis
conditions (Fig. 1B) and the ﬁnal conditions
for the assay were set at 1 h of incubation of
approximately 108 CFU of H. parasuis with
5 · 105 PAM per well (MOI = 100200).
The differences observed with the reference
strains were also detected with ﬁeld strains from
different clinical backgrounds: 3 nasal, 3 sys-
temic and 2 pulmonary (Tab. I). Incubation of
nasal strains with PAM resulted in a higher per-
centage of PAM with associated bacteria than
systemic strains: 40–90% PAM with associated1 http://rsb.info.nih.gov/ij
Figure 1. Optimization of basic conditions for
phagocytosis assay. Different quantities of FITC-
labelled bacteria (A) and different incubation times
of phagocytosis (B) were tested with PAM and
virulent (solid lines) or non-virulent (dashed lines)
strains. Results are shown as the percentage of
macrophages with green-ﬂuorescent bacteria
detected by ﬂow cytometry. The strains used were
Nagasaki (d), 264/99 (n), SW114 (s) and F9 (h).
In (B), bacterial inoculi were 5 · 108 CFU of
Nagasaki, 2 · 108 CFU of 264/99, 2 · 107 CFU of
SW114 and 2 · 107 CFU of F9.
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nasal strains versus 1–20% PAM with systemic
strains (Fig. 2, black bars). Although we
observed interexperimental variation with
PAM from different pigs, signiﬁcant differences
were found in all experiments between nasal
and systemic strains (Student’s T test of
independent experiments; P from 0.01 to
2.6 · 1016). In addition, when we pooled the
data from the individual experiments, we still
observed a clear difference between nasal and
systemic strains (Student’s T test; P =
2.2 · 1012). Furthermore, PAM inoculated
with nasal strains showed 2 to 15 times more
FITC-ﬂuorescence intensity compared to the
ones incubated with systemic strains.
Two of the systemic strains tested (Nagasaki,
and ER-6P) showed no association with PAM,
but strains 264/99 and PC4-6P consistently
showed a low level of association with the mac-
rophages. PAM inoculated with the two pul-
monary strains used in this study showed
different levels of associated FITC ﬂuores-
cence. While strain 167/03 showed a high
degree of association with PAM similar to that
of nasal strains (approximately 50% of PAM
with associated 167/03), strain 2757 associated
to a lesser degree (approximately 20% of PAM
with associated 2757).
The internalization of the FITC-labelled
non-virulent strains was conﬁrmed by ﬂow
cytometry and the speciﬁc antiserum to detect
extracellular bacteria (Fig. 2). In the case of
strains 264/99 and PC4-6P, the low association
with the PAM correlated with the majority of
bacteria being internalized, since no signiﬁcant
extracellular bacteria were detected (Fig. 2).
Internalization of bacteria was further con-
ﬁrmed by confocal microscopy (Fig. 3; and
on-line material only: supplementary informa-
tion for video available at www.vetres.org).
In survival assays, we also detected a greater
association (between 20 and 100 times) of nasal
Figure 2. Phagocytosis of H. parasuis strains by PAM. PAM (5 · 105 cells/well) were incubated with
different FITC-labelled strains of H. parasuis. After 1 h of incubation, extracellular bacteria were detected
with a H. parasuis-speciﬁc antiserum coupled with a phycoerythrin-secondary antibody. Macrophages were
then analysed by ﬂow cytometry. Results are presented as the percentages of cells associated with
ﬂuorescent bacteria (black bars), cells with bacteria inside (only green ﬂuorescence; dark gray bars) and
cells with bacteria on the surface (green and red ﬂuorescence; light gray bars). Inoculi of bacteria were:
109 CFU/well of Nagasaki; 2–4 · 108 CFU/well of 264/99, ER-6P and PC4-6P; 7–8 · 107 CFU/well of
SW114, F9 and SC14-1. Data are means and standard deviations from four independent experiments.
Phagocytosis resistance in H. parasuis Vet. Res. (2009) 40:24
(page number not for citation purpose) Page 5 of 12
strains to PAM after 1 h of phagocytosis (0.8%
and 2.0% of inoculum for SW114 and SC14-1,
respectively; 0.02% of inoculum for Nagasaki
and 264/99 and 0.05% for PC4-6P). Internal-
ized bacteria, independent of the strain, were
killed by PAM after 2 h.
Opsonization of virulent H. parasuis strains
with speciﬁc antibodies increased the associa-
tion of these bacteria with PAM to 60–80%,
similar to levels seen with the nasal strains.
Phagocytosis levels of the nasal strains were
not affected by antibody-opsonization (not
shown). Opsonization using a non-speciﬁc anti-
serum (directed against TCC) or a fresh rabbit
pre-immune serum was not successful in pro-
moting phagocytosis of systemic strains (not
shown), indicating that non-speciﬁc antibodies
or complement-opsonization did not have any
effect in the phagocytosis of H. parasuis.
3.2. Effect of in vitro passage
We used ER-6P, a virulent strain with a
known origin and passage history (ER-6P was
a direct isolate from the pericardium of a piglet
with Gla¨sser’s disease), to explore the effect of
in vitro passage on the phagocytosis susceptibil-
ity. To test this, we replated strain ER-6P on
chocolate agar every 2 days for 14 consecutive
passages. At that time, the culture was stored at
80 C and was designated ER-6Pp14. When
ER-6Pp14 was tested in the phagocytosis assay,
we observed that plate passage induced changes
in the original strain ER-6P, making it more
susceptible to phagocytosis (Fig. 4), i.e. the per-
centage of PAM with associated bacteria
increased noticeably. In addition to the
increased susceptibility to phagocytosis of
strain ER-6Pp14, we also observed other altered
phenotypes, such as larger colonies on choco-
late agar and increased auto-agglutination (not
shown).
3.3. Inhibition of phagocytosis
The association of nasal strains to PAM was
reduced at 4 C, indicating that the PAM have
to be active for the uptake and that probably
there is not a speciﬁc receptor for attachment
of these strains. The lack of speciﬁc receptor
was also supported by the competition assays
with non-labelled bacteria. We tried to compet-
itively inhibit the attachment and uptake of
FITC-labelled SW114 (107 CFU) with non-
labelled SW114 (107 or 108 CFU) and non-
labelled systemic strains (108, 109 or
1010 CFU). We observed that the phagocytosis
of the non-virulent strain SW114 by PAM could
not be blocked or reduced by homologous or
heterologous competition (not shown).
We sought to determine the role of the cyto-
skeletal components actin and microtubules in
the phagocytic uptake of H. parasuis. The addi-
tion of the actin ﬁlament inhibitor cytD before
and during the phagocytosis assay had a clear
effect on the internalization of non-virulent
strains (Fig. 5), although the inhibition was
not complete. Interestingly, uptake of virulent
Figure 3. Confocal images showing the association of virulent (ER6-P and PC4-6P) and non-virulent
(SW114) strains with PAM. The green signals correspond to FITC-labelled H. parasuis. PAM were stained
with rhodamine-phalloidin (red) to label the cytoplasm and the nuclei were counterstained with DAPI
(blue). Z stack images from two independent experiments were captured. Scale bar, 2 lm. (For a colour
version of this ﬁgure, please consult www.vetres.org.)
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strains PC4-6P and 264/99 was not affected by
cytD, indicating that these strains are entering
the PAM through a different mechanism than
non-virulent strains.
Inhibition of microtubules by colchicine par-
tially inhibited the internalization of nasal
strains SW114 and F9, but did not affect the
phagocytosis and internalization of SC14-1
Nagasaki 264/99          ER-6P          PC4-6P         SW114             F9             SC14-1        MU21-2 
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Figure 5. Effect of cytD on the phagocytosis of H. parasuis strains. FITC-labelled strains of H. parasuis
were incubated with PAM with (dashed bars) or without (plain bars) cytD. After 1 h, extracellular bacteria
were detected with a H. parasuis-speciﬁc antiserum coupled with a phycoerythrin-secondary antibody and
macrophages were analysed by ﬂow cytometry. Results are presented as the percentage of macrophages
with internalized bacteria (black bars) and surface associated bacteria (grey bars).
Figure 4. Effect of plate passage of strain ER-6P. Strain ER-6P and the same strain after 14 passages on
agar plates (ER-6Pp14) were tested with PAM for their susceptibility to phagocytosis. Both strains were
FITC-labelled and incubated with PAM. Extracellular bacteria were detected with a H. parasuis-speciﬁc
antiserum coupled with a PE-secondary antibody. Percentages of macrophages with FITC and PE
ﬂuorescence were detected by ﬂow cytometry. Figure shows representative results of three independent
experiments.
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and MU21-2. Phagocytosis of Nagasaki and
ER-6P was not affected by colchicine, but
phagocytosis of PC4-6P (Fig. 6) and 264/99
was signiﬁcatively increased (Student’s T test,
P = 0.037 and 0.008, respectively) by the
microtubule inhibitor. Overall, these results
demonstrate that there are several mechanisms
involved in the phagocytosis of H. parasuis
by PAM, and that there is a variable susceptibil-
ity of H. parasuis strains to this process.
To determine if there was a role for newly
synthesized proteins in the evasion process,
we used the bacterial protein synthesis inhibitor
chloramphenicol to block new protein synthe-
sis. When we used chloramphenicol, we
detected signiﬁcant increase (Student’s T test,
P < 0.05) in the susceptibility of the systemic
strains to phagocytosis (Fig. 7). However, the
level of phagocytosis in the presence of the
inhibitor remained moderate. In nasal strains,
the level of total phagocytosis was not affected
by chloramphenicol, but the level of internaliza-
tion was signiﬁcantly increased by the inhibitor
(Student’s T test, P < 0.05; Fig. 7).
3.4. Capsule production
Figure 8 shows the detection of capsule in
Nagasaki and PC4-6P strains before and after
incubation with macrophages. Similar results
were obtained with ER-6P and 264/99 strains.
Capsule was more evident in the systemic
strains after incubation with PAM than in their
initial inoculi, but capsule was not detected in
nasal strains before or after incubation with
PAM (not shown).
4. DISCUSSION
Although little is known about the virulence
mechanisms of H. parasuis, the ability of this
bacterium to reach and survive in the lung is
probably a key feature in producing disease.
Thus, resistance to pulmonary innate immune
defences, such as phagocytosis by alveolar
macrophages, could be a cornerstone for the
development of pneumonia or Gla¨sser’s
disease. In fact, the incubation of different
H. parasuis strains with PAM revealed differ-
ences that correlated with the clinical origin of
the strains. While strains isolated from systemic
lesions were resistant to phagocytosis, nasal
strains were efﬁciently phagocytosed by PAM,
and this interaction resulted in subsequent bac-
terial death. Additionally, resistance to phago-
cytosis by H. parasuis virulent strains could
be linked, at least partially, to capsule produc-
tion, since production of capsule was only seen
in strains that were resistant to phagocytosis.
In agreement with previous reports [27],
antibody-mediated (type I) phagocytosis was
highly efﬁcient for all strains. Indeed, it is well
known that pigs that produce a strong antibody
response against H. parasuis can survive a
homologous challenge. Thus, bacterial clear-
ance in the lung by type I phagocytosis will pre-
vent systemic infection and therefore, overcome
Gla¨sser’s disease. However, complement-medi-
ated (type II) phagocytosis did not result in
Figure 6. The effects of colchicine in phagocytosis
of strain PC4-6P. FITC-labelled strain PC4-6P was
used in phagocytosis assays to test the effects of
colchicine. After 1 h, extracellular bacteria were
detected with a H. parasuis-speciﬁc antiserum
coupled with a phycoerythrin-secondary antibody
and macrophages were analysed by ﬂow cytometry.
Results are presented as the percentage of macro-
phages with total bacteria (black bars), internalized
bacteria (dark grey bars) and surface associated
bacteria (light grey bars).
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Figure 7. Effect of inhibiting bacterial protein synthesis on phagocytosis. FITC-labelled strains of
H. parasuis were incubated with PAM in the presence of chloramphenicol (Cm; dashed bars) or without the
inhibitor (plain bars). After 1 h, extracellular bacteria were detected with a H. parasuis-speciﬁc antiserum
coupled with a phycoerythrin-secondary antibody and macrophages were analysed by ﬂow cytometry.
Results are presented as the percentage of macrophages with total bacteria (black bars), internalized bacteria
(dark grey bars) and surface associated bacteria (light grey bars).
Figure 8. Capsule detection by Maneval staining of bacterial smears. Strains Nagasaki (left panels) and
PC4-6P (right panels) were examined before (top panels) and after (bottom panels) incubation with PAM.
Capsule is observed as a white halo surrounding the bacterial body. (For a colour version of this ﬁgure,
please consult www.vetres.org.)
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efﬁcient phagocytosis of virulent strains of
H. parasuis. It is known that virulent H. para-
suis strains are resistant to serum [4] and, taking
into account that bacterial capsule is known to
interfere with complement deposition [3], it is
possible that opsonization by complement is
not effective in H. parasuis and therefore can
not mediate phagocytosis for the virulent,
encapsulated strains. Consequently, the innate
immune response will not be able to stop
H. parasuis infection, and a humoral response
will be needed. Competition assays showed that
there was not a speciﬁc receptor for the phago-
cytosis of H. parasuis, and contrary to other
members of the Pasteurellaceae family, such
as Haemophilus ducreyi or Histophilus somni
[9, 30], virulent strains did not inhibit the ability
of the macrophages to phagocytose other sus-
ceptible bacteria.
Our results suggest that several cellular
processes participate in the phagocytosis of
H. parasuis strains. Phagocytosis of non-viru-
lent nasal strains by PAM was efﬁcient and
dependent on actin ﬁlaments and active phago-
cytes. However, colchicine only demonstrated
strain dependent effects among the nasal strains
tested; indicating that there may be more than
one mechanism involved. The contribution of
bacterial products from the nasal strains on
phagocytosis was minor, since the inhibition
of bacterial protein synthesis by chlorampheni-
col resulted in no changes in the overall number
of cell associated (internal or external) bacteria,
although there was an increase in the
internalization.
Conversely, virulent strains resisted phago-
cytosis, and our data indicate that there may
be several mechanisms of evasion. First, the
observation of a more prominent capsule after
incubation of virulent bacteria with PAM sup-
ports a role for capsule in phagocytosis resis-
tance. Previous studies reported controversial
results about the presence or absence of capsule
in H. parasuis and its possible role in virulence
[17, 24]. In our experience, capsule in this bac-
terium is not easy to demonstrate (we did not
detect capsule in H. parasuis grown on agar
plates [4]), so the induction of capsule produc-
tion by incubation with PAM is a signiﬁcant
ﬁnding, and may help us to understand the reg-
ulation of capsule production. In addition, the
slight increase in phagocytosis susceptibility
observed with systemic strains after treatment
with the bacterial protein inhibitor chloram-
phenicol may indicate that there is an addi-
tional, proteinaceous factor involved in
phagocytosis resistance. Concurrently, systemic
strains showed two distinct phenotypes: while
strains Nagasaki and ER-6P showed negligible
association with the phagocytes, strains 264/99
and PC4-6P were internalized to some degree
by the PAM. Contrary to what was observed
for nasal strains, internalization of PC4-6P
and 264/99 by PAM was not affected by inhibi-
tion of actin polymerization, indicating that a
different mechanism of internalization was
involved. Surprisingly, the internalization of
systemic strains PC4-6P and 264/99 was
increased by inhibition of microtubules by col-
chicine. These results indicate a possible role of
microtubules in the mechanism of resistance of
these strains, which may produce an inhibitor
that would operate through a microtubule-
dependent pathway to block phagocytosis.
However, since these strains did not survive
inside the phagocytes, internalization of virulent
strains was discarded as an invasion mecha-
nism. Alternatively, recent reports point to the
existence of self-destructive cooperation in bac-
teria [1], in which one part of the population
‘‘sacriﬁces’’ for the survival of the rest. Curi-
ously, the existence of different phenotypic
sub-populations in strains of H. parasuis is
apparent by the existence of different colony
morphologies in some isolates, including strain
PC4-6P. The speciﬁc mechanisms involved in
this phenomenon still remain to be elucidated.
As it is known for other pathogens [6], we
detected striking changes in strain ER-6P after
in vitro passages. Our results show that adapta-
tion of the strain to laboratory conditions
yielded an attenuated phenotype for phagocyto-
sis and alteration of other traits, such as
increased autoagglutination. These results reit-
erate the importance of using ﬁeld strains with
low in vitro passage to study virulence in these
bacteria. This may be most important for repro-
ducibility of infection studies in animals, since
the number of passages could affect the number
of virulent bacteria in the inoculum.
Vet. Res. (2009) 40:24 A. Olvera et al.
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Interestingly, the results obtained in this
study with strain 167/03, demonstrate that while
this strain was originally taken as a pulmonary
isolate, it demonstrated a level of phagocytosis
susceptibility similar to nasal strains. This sup-
ports previous results that indicate that this
strain has characteristics of a non-virulent
strain. Strain 167/03 clustered by MLST with
nasal strains from healthy pigs from disease-
free farms [22] and was found to be serum sen-
sitive at a level similar to that of nasal strains
[4]. The clinical data of the strain also support
the same conclusion. Strain 167/03 was isolated
from the lung of an animal from a farm affected
with porcine reproductive and respiratory syn-
drome virus (PRRSV) and porcine circovirus
type 2 (PCV2). PCV2 is well known as an
immuno-suppressing virus [13, 26] and,
although there is some controversy about the
immunosuppressive effects of PRRSV, the fact
that this virus replicates primarily in alveolar
macrophages could affect the competence of
these cells to clear opportunistic pathogens such
as non-virulent strains of H. parasuis [18, 27].
Thus, we believe that strain 167/03 was able
to survive in the lungs where it was isolated
due to the suppressed immune status of the
host, not due to pathogenic mechanisms of
the bacteria. In contrast, strain 2757, which is
also a pulmonary isolate, showed features
which differed from those of strain 167/03.
Strain 2757 was isolated from a case of pneu-
monia and pleuritis and was classiﬁed by
MLST in a cluster of strains isolated from pneu-
monia cases. Also, strain 2757 was shown to be
serum-sensitive [4] but, in this study, we have
shown that strain 2757 is resistant to phagocy-
tosis by alveolar macrophages. All these data
support the idea that strain 2757 is a true pul-
monary strain; capable of producing pneumonia
(resistant to phagocytosis by alveolar macro-
phages) but not able to invade systemically
(sensitive to serum). This stresses that using
strains isolated from the lung can give mislead-
ing results.
In conclusion, we report for the ﬁrst time
that phagocytosis resistance is a virulence
mechanism of H. parasuis and that several fac-
tors may be involved in this function.
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